335 related articles for article (PubMed ID: 32663827)
1. Acute Kidney Injury and Special Considerations during Renal Replacement Therapy in Children with Coronavirus Disease-19: Perspective from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care.
Deep A; Bansal M; Ricci Z
Blood Purif; 2021; 50(2):150-160. PubMed ID: 32663827
[TBL] [Abstract][Full Text] [Related]
2. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.
Valle EO; Cabrera CPS; Albuquerque CCC; Silva GVD; Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Lins PRG; Rodrigues CE
Crit Care; 2021 Aug; 25(1):299. PubMed ID: 34412667
[TBL] [Abstract][Full Text] [Related]
3. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
[TBL] [Abstract][Full Text] [Related]
4. Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.
Reddy YNV; Walensky RP; Mendu ML; Green N; Reddy KP
Am J Kidney Dis; 2020 Nov; 76(5):696-709.e1. PubMed ID: 32730812
[TBL] [Abstract][Full Text] [Related]
5. Deployment of a New CRRT/PIRRT Device during the COVID-19 Pandemic Emergency: Organizational Challenges and Implementation Results.
Yessayan LT; Heung M; Girard FA; Shaikhouni S; Szamosfalvi B
Blood Purif; 2021; 50(3):390-398. PubMed ID: 33171460
[TBL] [Abstract][Full Text] [Related]
6. Ensuring Sustainability of Continuous Kidney Replacement Therapy in the Face of Extraordinary Demand: Lessons From the COVID-19 Pandemic.
Chua HR; MacLaren G; Choong LH; Chionh CY; Khoo BZE; Yeo SC; Sewa DW; Ng SY; Choo JC; Teo BW; Tan HK; Siow WT; Agrawal RV; Tan CS; Vathsala A; Tagore R; Seow TY; Khatri P; Hong WZ; Kaushik M
Am J Kidney Dis; 2020 Sep; 76(3):392-400. PubMed ID: 32505811
[TBL] [Abstract][Full Text] [Related]
7. [Multidisciplinary management of a typical case of acute kidney failure in the course of COVID-19 infection].
Caputo C; Ciabattoni M; Garneri D; Repetto M; Santoni O; Tarroni A; Tosetti F; Vigo EC; Mancuso G
G Ital Nefrol; 2020 Oct; 37(5):. PubMed ID: 33026202
[TBL] [Abstract][Full Text] [Related]
8. Continuous renal replacement therapy in neonates and children: what does the pediatrician need to know? An overview from the Critical Care Nephrology Section of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC).
Cortina G; Daverio M; Demirkol D; Chanchlani R; Deep A
Eur J Pediatr; 2024 Feb; 183(2):529-541. PubMed ID: 37975941
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012467. PubMed ID: 33314078
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F; Westermann L; Rieg S; Neumann-Haefelin E; Biever PM; Walz G; Kalbhenn J; Tanriver Y
BMC Nephrol; 2020 Nov; 21(1):486. PubMed ID: 33198670
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto H; Tsujimoto Y; Nakata Y; Fujii T; Takahashi S; Akazawa M; Kataoka Y
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012467. PubMed ID: 32164041
[TBL] [Abstract][Full Text] [Related]
12. Clinical effect and safety of continuous renal replacement therapy in the treatment of neonatal sepsis-related acute kidney injury.
Cai C; Qiu G; Hong W; Shen Y; Gong X
BMC Nephrol; 2020 Jul; 21(1):286. PubMed ID: 32682407
[TBL] [Abstract][Full Text] [Related]
13. Regional citrate and systemic heparin are adequate to maintain filter half-life for COVID-19 patients on continuous renal replacement therapy.
Chiao C; Faust H; Singh T
Semin Dial; 2022 Jul; 35(4):325-329. PubMed ID: 35141966
[TBL] [Abstract][Full Text] [Related]
14. Continuous renal replacement therapy and the COVID pandemic.
Stevens JS; Velez JCQ; Mohan S
Semin Dial; 2021 Nov; 34(6):561-566. PubMed ID: 33705575
[TBL] [Abstract][Full Text] [Related]
15. Filter clotting with continuous renal replacement therapy in COVID-19.
Endres P; Rosovsky R; Zhao S; Krinsky S; Percy S; Kamal O; Roberts RJ; Lopez N; Sise ME; Steele DJR; Lundquist AL; Rhee EP; Hibbert KA; Hardin CC; Mc Causland FR; Czarnecki PG; Mutter W; Tolkoff-Rubin N; Allegretti AS
J Thromb Thrombolysis; 2021 May; 51(4):966-970. PubMed ID: 33026569
[TBL] [Abstract][Full Text] [Related]
16. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
[TBL] [Abstract][Full Text] [Related]
18. Management of Acute Kidney Injury in Coronavirus Disease 2019.
Shaikh S; Matzumura Umemoto G; Vijayan A
Adv Chronic Kidney Dis; 2020 Sep; 27(5):377-382. PubMed ID: 33308502
[TBL] [Abstract][Full Text] [Related]
19. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial.
Meersch M; Küllmar M; Wempe C; Kindgen-Milles D; Kluge S; Slowinski T; Marx G; Gerss J; Zarbock A;
BMJ Open; 2019 Jan; 9(1):e024411. PubMed ID: 30670518
[TBL] [Abstract][Full Text] [Related]
20. [The COVID-19 pandemic and hemodialysis: a multicentric experience].
Previti A; Lentini P; Di Caprio A; Marchiori M; Dell'Aquila R
G Ital Nefrol; 2020 Dec; 37(6):. PubMed ID: 33295703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
